Adrenal Hyperplasia, Congenital: all 109 studies

Page 1 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• An Extension Trial of Asedebart in Participants With Congenital Adrenal HyperplasiaNot yet recruitingNCT07859293Phase 2
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBIP-01435 in Adult Participants With Classic Congenital Adrenal Hyperplasia (CAH)Not yet recruitingNCT07850739Phase 2
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OMS1620Not yet recruitingNCT07811089Phase 1
• Pediatric Congenital Adrenal Hyperplasia Management: Regret and Long-term OutcomesRecruitingNCT07781267
• Evaluation of Circadian Hormonal Balance: LC-MS/MS Measurement of Salivary and Serum Steroids in Patients With Congenital Adrenal HyperplasiaNot yet recruitingNCT07718230
• Hydrocortisone Modified-release in Adults: Real-world Monitoring of Longitudinal Outcomes in coNgenital Adrenal hYperplasiaNot yet recruitingNCT07622030
• Development of Healthcare Transition for Patients With Congenital Adrenal HyperplasiaNot yet recruitingNCT07611786
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years OldRecruitingNCT07536269Phase 2
• Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)RecruitingNCT07473804
• Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)RecruitingNCT07247058Phase 4
• A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)RecruitingNCT07159841Phase 2/3
• A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaRecruitingNCT07144163Phase 3
• Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACSRecruitingNCT07138274Phase 2
• Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)RecruitingNCT07104812Phase 2
• Fertility And Sexual Function In CAH: CALLIOPERecruitingNCT07099456
• Parenting and CAH - 21-hydroxylase DeficiencyRecruitingNCT06900153
• Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase DeficiencyRecruitingNCT06754423
• An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal HyperplasiaRecruitingNCT06712823Phase 2
• Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-PentixatherRecruitingNCT06581744Not applicable
• Institutional Registry of Rare DiseasesRecruitingNCT06573723
• Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children HospitalNot yet recruitingNCT06564220
• Water and Electrolytes Content in HYpertension (WHYSKI) in the SKInRecruitingNCT06090617
• Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyRecruitingNCT06050057
• A Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaRecruitingNCT05669950Phase 1/2
• China Adrenal Disease RegistryRecruitingNCT04890444
• GROWing Up With Rare GENEtic SyndromesRecruitingNCT04463316
• Growing up With the Young Endocrine Support System (YESS!)Not yet recruitingNCT04252001Not applicable
• Congenital Adrenal Hyperplasia Once Daily Hydrocortisone TreatmentRecruitingNCT03760835Phase 4
• Natural History Study of Patients With Excess AndrogenRecruitingNCT00250159
• Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)CompletedNCT05907291Phase 2Results posted
• A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAHTerminatedNCT05128942Phase 2Results posted
• Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaCompletedNCT05063994Phase 3Results posted
• Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)Active, not recruitingNCT04806451Phase 3Results posted
• A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAHTerminatedNCT04544410Phase 2Results posted
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal HyperplasiaActive, not recruitingNCT04490915Phase 3Results posted
• A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAHTerminatedNCT04457336Phase 2Results posted
• Calcium Channel Blockade in Primary AldosteronismCompletedNCT04179019Phase 2Results posted
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal HyperplasiaCompletedNCT04045145Phase 2Results posted
• Subcutaneous Hydrocortisone Children With Congenital Adrenal HyperplasiaCompletedNCT03718234Phase 1Results posted
• Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal HyperplasiaCompletedNCT03687242Phase 2Results posted
• Nevanimibe HCl for the Treatment of Classic CAHTerminatedNCT03669549Phase 2Results posted
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal HyperplasiaCompletedNCT03525886Phase 2Results posted
• Study of SPR001 in Adults With Classic Congenital Adrenal HyperplasiaCompletedNCT03257462Phase 2Results posted
• A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAHCompletedNCT03062280Phase 3Results posted
• A Study of ATR-101 for the Treatment of Congenital Adrenal HyperplasiaCompletedNCT02804178Phase 2Results posted
• Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal HyperplasiaCompletedNCT02716818Phase 3Results posted
• Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1TerminatedNCT02574910Phase 1Results posted
• Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal HyperplasiaCompletedNCT01859312Phase 2Results posted
• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAHCompletedNCT01735617Phase 2Results posted
• Dexamethasone Treatment of Congenital Adrenal HyperplasiaCompletedNCT00621985Phase 2Results posted
• Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal HyperplasiaCompletedNCT00519818Phase 1/2Results posted
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal HyperplasiaCompletedNCT00001521Phase 3Results posted
• Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years OldActive, not recruitingNCT07187375Phase 2
• Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase DeficiencyCompletedNCT06756620
• Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in ItalyCompletedNCT06728748
• Exercise Capacity, Physical Fitness, and Physical Activity Levels in Children With CAHCompletedNCT06449456
• Fertility and Pregnancy in Patients With Classic Congenital Adrenal HyperplasiaCompletedNCT06153043
• Metyrapone for Mild Autonomous Cortisol Secretion (MACS)Active, not recruitingNCT06106295Phase 2
• Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
• A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal HyperplasiaWithdrawnNCT05663320Not applicable
• The Effect of Low Sodium Diet on Idiopathic HyperaldosteronismCompletedNCT05649631Not applicable
• Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal HyperplasiaCompletedNCT05299554Phase 3
• Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia IndividualsStatus unknownNCT05228652
• Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort StudyStatus unknownNCT05186675Not applicable
• Effects and Importance of Epinephrine/Adrenalin Deficiency in CAHStatus unknownNCT05162950
• A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])CompletedNCT05101902
• Gonadal Changes In Congenital Adrenal Hyperplasia PatientsStatus unknownNCT04903587
• A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)Active, not recruitingNCT04783181Phase 1/2
• Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase DeficiencyStatus unknownNCT04536662Phase 4
• Outcome of Patients With Primary AldosteronismStatus unknownNCT04428827
• Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary AldosteronismCompletedNCT04378387
• Final Height in Patients With CAHStatus unknownNCT04293133
• Linear Growth of Children With Congenital Adrenal HyperplasiaStatus unknownNCT04087148
• Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical ConditionsCompletedNCT04071561
• Surgical Evaluation of Using the Prepuce in Feminizing GenitoplastyStatus unknownNCT03897504Not applicable
• LC-MS / MS Adrenal Steroids Assayed on Dried Blot Spot for the Congenital Adrenal Hyperplasia Neonatal Screening (SPECTROSPOT)CompletedNCT03589144
• Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal HyperplasiaCompletedNCT03550261
• Androgen Reduction in Congenital Adrenal HyperplasiaWithdrawnNCT03548246Phase 2
• Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement TherapyWithdrawnNCT03532022Phase 3
• Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary AldosteronismCompletedNCT03174847
• Growth Hormone (GH) in Congenital Adrenal HyperplasiaCompletedNCT03162172
• Adult Height Prediction in Congenital Adrenal HyperplasiaCompletedNCT03162159
• A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort FormulationsCompletedNCT03051893Phase 1
• An Open Label Study in Healthy Volunteers to Compare Chronocort® to HydrocortisoneCompletedNCT03019614Phase 1
• Dynamic Hormone Diagnostics in Endocrine DiseaseCompletedNCT02934399
• Prenatal Dex StudyCompletedNCT02795871Not applicable
• COrticosteroid in Congenital Adrenal HyperplasiaStatus unknownNCT02552251Phase 2/3
• Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnNCT02349503Phase 1
• Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal HyperplasiaCompletedNCT02096510Phase 1/2
• Decision Support for Parents Receiving Information About Child's Rare DiseaseCompletedNCT01875640
• Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.Status unknownNCT01862380Not applicable
• Cardiovascular Risk Profile in Patients With Congenital Adrenal HyperplasiaCompletedNCT01807364
• Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal HyperplasiaStatus unknownNCT01771328Phase 2
• A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)TerminatedNCT01661387
• A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase DeficiencyCompletedNCT01495910Phase 1
• Clinical Evaluation of NeoPlex4 Assay and NeoPlex SystemCompletedNCT01488721
• Adrenal Hyperplasia Among Young People With PCOSCompletedNCT01313455
• Tweens to Teens Project at Penn StateCompletedNCT01184651
• Study of UK Adults With Congenital Adrenal Hyperplasia.CompletedNCT00749593
• Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal HyperplasiaStatus unknownNCT00694525

← Adrenal Hyperplasia, Congenital overview